Effectiveness of levamisole in the treatment of patients with severe COVID-19: a randomized controlled clinical trial

Effectiveness of levamisole in the treatment of patients with severe COVID-19: a randomized controlled clinical trial

Introduction: Inflammation plays a role in coronavirus disease 2019 (COVID-19) pathophysiology and anti-inflammatory drugs may help reduce the disease severity. Levamisole is an anthelmintic drug with immunomodulatory and possible antiviral effects. This study aimed to evaluate the role of levamiso...

Full description

Saved in:
Bibliographic Details
Main Authors: Morteza Pourahmad, Rasool Soltani, Mohammad H Noroozi, Farzin Khorvash, Behrooz Ataei, Manijeh Shams, Fatemeh Nikokar
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2024-12-01
Series:Journal of Infection in Developing Countries
Subjects:
Levamisole
COVID-19
inflammation
immune response
clinical trial
Online Access:https://jidc.org/index.php/journal/article/view/18659
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jidc.org/index.php/journal/article/view/18659

Similar Items